CT45A1 siRNA silencing suppresses the proliferation, metastasis and invasion of lung cancer cells by downregulating the ERK/CREB signaling pathway

Tang,Feng; Tang,Shengjun; Guo,Xiaolong; Yang,Chao; Jia,Ke

doi:10.3892/mmr.2017.7466

CT45A1 siRNA silencing suppresses the proliferation, metastasis and invasion of lung cancer cells by downregulating the ERK/CREB signaling pathway

Authors:
- Feng Tang
- Shengjun Tang
- Xiaolong Guo
- Chao Yang
- Ke Jia
View Affiliations

Affiliations: Department of Thoracic Surgery, Three Gorges Center Hospital, Chongqing 404000, P.R. China, Department of Cardiothoracic Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan 637000, P.R. China
Published online on: September 12, 2017 https://doi.org/10.3892/mmr.2017.7466
Pages: 6708-6714
Copyright: © Tang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to investigate the role of the cancer‑testis antigen family 45 member A1 (CT45A1) in the proliferation, apoptosis, invasion and metastasis of lung cancer cells, and the associated molecular mechanisms. Western blotting determined that the expression of CT45A1 in normal lung cells was far lower than that observed in lung cancer cells. Following the transfection of CT45A1 small (or short) interfering (si)RNA and its negative control into A549 cells using Lipofectamine 2000, the CT45A1 protein and mRNA levels were determined further by western blotting and reverse transcription‑polymerase chain reaction. Following CT45A1 siRNA transfection, the levels of CT45A1 in lung cancer cells were markedly reduced (P<0.01). Then, cell viability and apoptosis were investigated with a methyl thiazolyl tetrazolium assay and Annexin V‑FITC/propidium iodide staining, respectively. Transwell assays were employed to evaluate the migration and invasion of A549 cells. When compared with the negative control, the viability, migration and invasion of lung cancer cells treated with CT45A1 siRNA were suppressed and apoptosis was promoted (all P<0.01). In addition, the levels of B‑cell lymphoma‑2 (Bcl‑2), Bcl‑2 associated X (Bax), survivin, matrix metalloproteinase 2 (MMP2), MMP9, extracellular signal‑regulated kinase 1/2 (ERK1/2), phosphorylated ERK1/2 (p‑ERK1/2), cyclic AMP response element binding protein (CREB) and p‑CREB were assessed by western blotting. Following CT45A1 silencing, the expressions of Bcl‑2, survivin, MMP2, MMP9, p‑ERK1/2 and p‑CREB were downregulated and the expression of Bax was upregulated (all P<0.01). It was concluded that CT45A1 siRNA silencing suppressed the proliferation, metastasis and invasion of lung cancer cells by downregulating the ERK/CREB signalling pathway.

View Figures

View References

1	Alvarado-Luna G and Morales-Espinosa D: Treatment for small cell lung cancer, where are we now?-a review. Transl Lung Cancer Res. 5:26–38. 2016.PubMed/NCBI
2	Awad R and Nott L: Radiation recall pneumonitis induced by erlotinib after palliative thoracic radiotherapy for lung cancer: Case report and literature review. Asia Pac J Clin Oncol. 12:91–95. 2016. View Article : Google Scholar : PubMed/NCBI
3	Liu XZ, Zhang LT, Tong WQ, Wang W, Xu ZB and Chen F: Research advances in molecular mechanisms of the invasion and metastasis of lung cancer. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 38:108–112. 2016.PubMed/NCBI
4	Wang H, Zhang G and Min J: Research advances of cell apoptosis mechanisms in lung cancer. J Med Res. 40:25–27. 2011.
5	Chen YT, Hsu M, Lee P, Shin SJ, Mhawech-Fauceglia P, Odunsi K, Altorki NK, Song CJ, Jin BQ, Simpson AJ and Old LJ: Cancer/testis antigen CT45: Analysis of mRNA and protein expression in human cancer. Int J Cancer. 124:2893–2898. 2009. View Article : Google Scholar : PubMed/NCBI
6	Zhou X, Yang F, Zhang T, Zhuang R, Sun Y, Fang L, Zhang C, Ma Y, Huang G, Ma F, et al: Heterogeneous expression of CT10, CT45 and GAGE7 antigens and their prognostic significance in human breast carcinoma. Jpn J Clin Oncol. 43:243–250. 2013. View Article : Google Scholar : PubMed/NCBI
7	Zhang W, Barger CJ, Link PA, Mhawech-Fauceglia P, Miller A, Akers SN, Odunsi K and Karpf AR: DNA hypomethylation-mediated activation of cancer/testis antigen 45 (CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer. Epigenetics. 10:736–748. 2015. View Article : Google Scholar : PubMed/NCBI
8	Chen YT, Panarelli NC, Piotti KC and Yantiss RK: Cancer-testis antigen expression in digestive tract carcinomas: Frequent expression in esophageal squamous cell carcinoma and its precursor lesions. Cancer Immunol Res. 2:480–486. 2014. View Article : Google Scholar : PubMed/NCBI
9	Chen YT, Scanlan MJ, Venditti CA, Chua R, Theiler G, Stevenson BJ, Iseli C, Gure AO, Vasicek T, Strausberg RL, et al: Identification of cancer/testis-antigen genes by massively parallel signature sequencing. Proc Natl Acad Sci USA. 102:7940–7945. 2005; View Article : Google Scholar : PubMed/NCBI
10	Gao A: The effect and mechanism of CT45A1 gene promoting the invasion and metastasis of lung cancer cells. Suzhou University Suzhou. 2015.
11	van der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, van den Eynde B, Knuth A and Boon T: A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science. 254:1643–1647. 1991. View Article : Google Scholar : PubMed/NCBI
12	Koop A, Sellami N, Adam-Klages S, Lettau M, Kabelitz D, Janssen O and Heidebrecht HJ: Down-regulation of the cancer/testis antigen 45 (CT45) is associated with altered tumor cell morphology, adhesion and migration. Cell Commun Signal. 11:412013. View Article : Google Scholar : PubMed/NCBI
13	Yaren A, Oztop I, Kargi A, Ulukus C, Onen A, Sanli A, Binicier O, Yilmaz U and Alakavuklar M: Bax, bcl-2 and c-kit expression in non-small-cell lung cancer and their effects on prognosis. Int J Clin Pract. 60:675–682. 2006. View Article : Google Scholar : PubMed/NCBI
14	Hirano H, Maeda H, Yamaguchi T, Yokota S, Mori M and Sakoda S: Survivin expression in lung cancer: Association with smoking, histological types and pathological stages. Oncol Lett. 10:1456–1462. 2015.PubMed/NCBI
15	Zhang DH, Zhang LY, Liu DJ, Yang F and Zhao JZ: Expression and significance of MMP-9 and MDM2 in the oncogenesis of lung cancer in rats. Asian Pac J Trop Med. 7:585–588. 2014. View Article : Google Scholar : PubMed/NCBI
16	El-Badrawy MK, Yousef AM, Shaalan D and Elsamanoudy AZ: Matrix metalloproteinase-9 expression in lung cancer patients and its relation to serum mmp-9 activity, pathologic type, and prognosis. J Bronchology Interv Pulmonol. 21:327–334. 2014. View Article : Google Scholar : PubMed/NCBI
17	Meng G, Wang W, Chai K, Yang S, Li F and Jiang K: Combination treatment with triptolide and hydroxycamptothecin synergistically enhances apoptosis in A549 lung adenocarcinoma cells through PP2 A-regulated ERK, p38 MAPKs and Akt signaling pathways. Int J Oncol. 46:1007–1017. 2015. View Article : Google Scholar : PubMed/NCBI
18	Lv K, Shi R and Zhu J: Expression and significance of CREB and CXCR2 in lung squamous cell carcinoma and adenocarcinoma. Chin J Histochem Cytochem. 23:257–260. 2014.(In Chinese).
19	Peng B, Lei N, Chai Y, Chan EK and Zhang JY: CIP2A regulates cancer metabolism and CREB phosphorylation in non-small cell lung cancer. Mol Biosyst. 11:105–114. 2015. View Article : Google Scholar : PubMed/NCBI
20	Takezawa K, Okamoto I, Nishio K, Jänne PA and Nakagawa K: Role of ERK-BIM and STAT3-survivin signaling pathways in ALK inhibitor-induced apoptosis in EML4-ALK-positive lung cancer. Clin Cancer Res. 17:2140–2148. 2011. View Article : Google Scholar : PubMed/NCBI
21	Wong JC, Bathina M and Fiscus RR: Cyclic GMP/protein kinase G type-Iα (PKG-Iα) signaling pathway promotes CREB phosphorylation and maintains higher c-IAP1, livin, survivin, and Mcl-1 expression and the inhibition of PKG-Iα kinase activity synergizes with cisplatin in non-small cell lung cancer cells. J Cell Biochem. 113:3587–3598. 2012. View Article : Google Scholar : PubMed/NCBI
22	Zhou WJ, Wang S, Hu Z, Zhou ZY and Song CJ: Angelica sinensis polysaccharides promotes apoptosis in human breast cancer cells via CREB-regulated caspase-3 activation. Biochem Biophys Res Commun. 467:562–569. 2015. View Article : Google Scholar : PubMed/NCBI
23	Ko HS, Park BJ, Choi SK, Kang HK, Kim A, Kim HS, Park IY and Shin JC: STAT3 and ERK signaling pathways are implicated in the invasion activity by oncostatin M through induction of matrix metalloproteinases 2 and 9. Yonsei Med J. 57:761–768. 2016. View Article : Google Scholar : PubMed/NCBI
24	Ryu BJ, Lee H, Kim SH, Heo JN, Choi SW, Yeon JT, Lee J, Lee J, Cho JY, Kim SH and Lee SY: PF-3758309, p21-activated kinase 4 inhibitor, suppresses migration and invasion of A549 human lung cancer cells via regulation of CREB, NF-κB and β-catenin signalings. Mol Cell Biochem. 389:69–77. 2014. View Article : Google Scholar : PubMed/NCBI
25	Shang B, Gao A, Pan Y, Zhang G, Tu J, Zhou Y, Yang P, Cao Z, Wei Q, Ding Y, et al: CT45A1 acts as a new proto-oncogene to trigger tumorigenesis and cancer metastasis. Cell Death Dis. 5:e12852014. View Article : Google Scholar : PubMed/NCBI